BREAKING THROUGH TO FUNDING CANCER RESEARCH CLINICAL TRIALS
Gateway for Cancer Research accelerates practice-changing discoveries in cancer care by harnessing the unrelenting passion of the research community and empowering patients to triumph over their disease. All of this is guided by a clear vision: To shape a world in which a cancer diagnosis is no longer feared.
Explore Gateway’s cutting-edge cancer research program
Learn more about Gateway for Cancer Research and our critical mission
Donate to cancer research today and help advance lifesaving cancer research
GATEWAY FOR CANCER RESEARCH STORIES
Read about the unwavering patients and the cancer researchers who are helping us put and end to cancer as we know it.
10,000+ patients have been impacted by Gateway for Cancer Research funded clinical trials to date.READ MORE
Patient Profile: Curt
Curt enrolled in a Gateway-funded cancer research trial to treat his kidney cancer. See what he and his doctor had to say about his experience in this trial.Watch Curt’s Story
Why Give to Gateway
100% of all donations directly fund early phase clinical cancer research.DONATE NOW
Get your Copy of GLOW Today!
Support Gateway for Cancer Research and get your free GLOW book today.Find out how here
“Never again am I going to look at a birthday and say, ‘I can’t believe I’m going to be another year older.’ Now I’m saying, ‘I’m so glad to be another year older!’”
- Beth, lymphoma patient in a Gateway-funded trial
Gateway-funded pancreas cancer clinical trail at OSU expanding with drug manufacturer support.Read More
Did You Know?
227 clinical trials have been funded worldwide by Gateway for Cancer Research since 1991.View Our Clinical Trials
Fund One Day
It costs just $19.62 per patient per day in a Gateway-funded cancer clinical trial.
Help us fund another day of research, another week or more. You can even mark your gift with a special date, such as an anniversary, birthday, wedding, bar/bat mitzvah or graduation.
LATEST CANCER RESEARCH
Gateway for Cancer Research only invests in Phase I and Phase II human clinical trials where true innovation and transformational discoveries happen.
Trial Type: Pediatric Blood Cancer
Phase I/II Trial of Trivalent CAR T cells in Acute Lymphoblastic Leukemia
Nabil Ahmed, MD, MPH
Baylor College of Medicine
Trial Type: Kidney Cancer
Clinical TrialPhase II Trial of Relatlimab plus Nivolumab in Renal Medullary Carcinoma
Pavlos Msaouel, MD PhD
MD Anderson Cancer Center